Sarepta Therapeutics Inc (SRPT)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

215 FIRST STREET CAMBRIDGE, MA 02142

Sarepta Therapeutics develops products for the treatment of life-threatening diseases, including cardiovascular disease, infectious disease and cancer. Its therapeutic products are principally based on NeuGene antisense technology.

Data based on most recent fiscal year report
Market Cap4.69 Billion Shares Outstanding64.63 Million Avg Volume3.299 Million
1-Yr BETA vs S&P TR Current Ratio13.91 Quick Ratio12.96
View SEC Filings from SRPT instead.
Q3 2019 All Institutions Hedge Funds 1
To trade SRPT now:
Filers who had this stock in their top 10: 6 6 (0.63%)
13F Filers holding this stock: 322 46 (4.81%)
Aggregate 13F shares on 09/30/2019: 70.538 Million 12.718 Million
Aggregate 13F shares on 06/30/2019: 70.597 Million 10.422 Million
Percent change: -0.08% 22.03%
Funds creating new positions: 70 15
Funds Adding to an existing position: 119 20
Funds closing out their position: 90 28
Funds reducing their position: 99 9
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding SRPT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

25 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

34.3 Thousand total shares from 7 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HOWTON DAVID T EVP, GENERAL COUNSEL

  • Officer
25,171 2019-11-22 4

CASEY MICHAEL D

0 2019-11-20 0

BONNEY MICHAEL W

0 2019-11-20 2

CIAMBRONE WILLIAM EVP

  • Officer
0 2019-11-18 2

BEHRENS M KATHLEEN

  • Director
62,500 2019-09-18 2

BARRY RICHARD

  • Director
3,187,065 2019-09-12 5

MAHATME SANDESH EVP, CFO & CBO

  • Officer
42,191 2019-08-21 7

INGRAM DOUGLAS S PRESIDENT & CEO

  • Officer
  • Director
432,197 2019-08-12 1

CHASE ANTHONY R

  • Director
0 2019-08-08 0

GRAY MARY ANN

  • Director
7,355 2019-07-19 3

KAYE EDWARD M. MD CEO

  • Officer
  • Director
0 2019-06-18 0

CUMBO ALEXANDER

  • Director
0 2019-06-11 3

PRICE BEN GIL

0 2019-06-06 0

HENNEY CHRISTOPHER S

  • Director
0 2019-05-29 0

WIGZELL HANS LENNART RUDOLF

  • Director
11,717 2019-05-23 2

O'NEILL GILMORE NEIL EVP, R&D & CMO

  • Officer
7,370 2019-05-23 2

NICAISE CLAUDE

  • Director
7,051 2019-03-04 1

O'NEILL GILMORE NEIL EVP, R&D & CMO

O'NEILL GILMORE NEIL EVP, R&D & CMO

  • Officer
0 2019-03-04 2

JACOBSEN MICHAEL A VP FINANCE AND CAO

  • Officer
0 2019-02-08 0

APHALE JAYANT SEE REMARKS

  • Officer
0 2018-09-27 0

RUFF SHAMIM SVP, CHIEF REGULATORY AFFAIRS

  • Officer
31,936 2018-05-22 0

HAYWOOD GEORGE WEAVER

  • Director
0 2018-05-09 0

BASI GURIQBAL S. SVP, CHIEF SCIENTIFIC OFFICER

  • Officer
0 2018-03-05 0

KRESS JEAN-PAUL EVP PRES INT'L & GLOBAL HD GTO

  • Officer
0 2017-07-03 0

STEHMAN-BREEN CATHERINE SVP, CHIEF MEDICAL OFFICER

  • Officer
0 2017-04-03 0

WOOD JOAN VP, HUMAN RESOURCES

  • Officer
14,926 2016-09-20 0

SHREWSBURY STEPHEN B CMO; SENIOR VP CLINICAL DEV.

  • Officer
0 2016-03-10 0

GOOLSBEE WILLIAM ALDEN

  • Director
8,166 2016-02-29 0

TIMMINS ALAN P

  • Director
0 2015-07-30 0

HODGMAN JOHN

  • Director
6,333 2015-02-27 0

CHRISTOPHER NISHAN GARABEDIAN PRESIDENT AND CEO

  • Officer
  • Director
29,552 2015-02-27 0

KRIEG ARTHUR M SVP, CHIEF SCIENTIFIC OFFICER

  • Officer
0 2014-01-13 0

MARTIGNETTI ANTHONY

  • SEE REMARKS
0 2013-06-04 0

BOYLE J DAVID II SENIOR VP AND CFO

  • Officer
0 2012-01-04 0

TOSHAV BRACHA EPHRAT SR VP & GENERAL COUNSEL

  • Officer
0 2011-08-31 0

MILE MELINDA G CONTROLLER AND PAO

  • Officer
0 2011-08-31 0

LINSLEY PETER S SVP & CHIEF SCIENTIFIC OFFICER

  • Officer
0 2011-05-16 0

IVERSEN PATRICK L SR VP OF RESEARCH & DEVLOPMENT

  • Officer
0 2010-08-23 0

WELLER DWIGHT D SR. VP CHEMISTRY & MFG.

  • Officer
0 2010-08-23 0

MEDEIROS PAUL SVP BUSINESS DEVELOPMENT

  • Officer
0 2010-08-23 0

JOHNSON GRAHAM SR VP PRECLINICAL DEV & RSRCH

  • Officer
0 2010-08-23 0

HUDSON LESLIE FORMER CEO

  • Officer
  • FORMER CEO
384,559 2010-07-30 0

EASTBOURNE CAPITAL MANAGEMENT LLC/CA

  • 10% Owner
No longer subject to file 2010-05-10 0

ROCKALL EMERGING MARKETS MASTER FUND LTD

O'DRISCOLL CONOR

EGAN CON

MELDRUM ASSET MANAGEMENT, LLC

  • MAY BE DEEMED 10% GROUP MEMBERMAY BE DEEMED 10% GROUP MEMBERMAY BE DEEMED 10% GROUP MEMBERMAY BE DEEMED 10% GROUP MEMBER
2,935,696 2010-03-16 0

HAYWOOD GEORGE WEAVER

HAYWOOD CHERYL

  • MAY BE DEEMED 10% GROUP MEMBERMAY BE DEEMED 10% GROUP MEMBER
8,329,126 2010-03-16 0

KOLE RYSZARD SVP/DISCOVERY RESEARCH

  • Officer
1,862,926 2010-02-09 0

BLACK BEAR OFFSHORE MASTER FUND LP

  • 10% Owner
7,971,542 2009-09-28 0

FORREST K MICHAEL OUTSIDE DIRECTOR

  • Officer
  • Director
15,000 2009-05-19 0

FARA JOHN W PHD

  • Director
  • DIRECTOR
500 2008-05-20 0

OHANLEY PETER D SR. VICE PRESIDENT

  • Officer
0 2008-02-28 0

WEBBER MARK MILES CFO

  • Officer
15,446 2008-02-02 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

HOWTON DAVID T - Officer EVP, GENERAL COUNSEL

2019-11-22 M 5,590 d 0 25,171.00 direct

HOWTON DAVID T - Officer EVP, GENERAL COUNSEL

2019-11-22 M 8,580 d 18,579 25,171.00 direct yes

HOWTON DAVID T - Officer EVP, GENERAL COUNSEL

2019-11-22 F 2,804 $107.02 d 25,171 25,171.00 direct

HOWTON DAVID T - Officer EVP, GENERAL COUNSEL

2019-11-22 M 52 $13.71 a 14,485 25,171.00 direct

HOWTON DAVID T - Officer EVP, GENERAL COUNSEL

2019-11-22 S 3,753 $105.00 d 14,950 25,171.00 direct yes

HOWTON DAVID T - Officer EVP, GENERAL COUNSEL

2019-11-22 M 4,025 $13.71 a 28,413 25,171.00 direct yes

HOWTON DAVID T - Officer EVP, GENERAL COUNSEL

2019-11-22 M 52 d 18 25,171.00 direct

HOWTON DAVID T - Officer EVP, GENERAL COUNSEL

2019-11-22 M 4,025 d 1,858 25,171.00 direct yes

HOWTON DAVID T - Officer EVP, GENERAL COUNSEL

2019-11-22 M 7,900 $23.85 a 27,975 25,171.00 direct

HOWTON DAVID T - Officer EVP, GENERAL COUNSEL

2019-11-22 M 2,440 $13.71 a 14,433 25,171.00 direct

HOWTON DAVID T - Officer EVP, GENERAL COUNSEL

2019-11-22 S 18,290 $105.00 d 18,703 25,171.00 direct yes

HOWTON DAVID T - Officer EVP, GENERAL COUNSEL

2019-11-22 M 5,685 $13.71 a 24,388 25,171.00 direct yes

HOWTON DAVID T - Officer EVP, GENERAL COUNSEL

2019-11-22 M 7,900 d 5,118 25,171.00 direct

HOWTON DAVID T - Officer EVP, GENERAL COUNSEL

2019-11-22 M 2,440 d 2,470 25,171.00 direct

HOWTON DAVID T - Officer EVP, GENERAL COUNSEL

2019-11-22 M 5,685 d 1,280 25,171.00 direct yes

HOWTON DAVID T - Officer EVP, GENERAL COUNSEL

2019-11-22 M 5,590 $13.90 a 20,075 25,171.00 direct

HOWTON DAVID T - Officer EVP, GENERAL COUNSEL

2019-11-22 S 2,957 $105.00 d 11,993 25,171.00 direct yes

HOWTON DAVID T - Officer EVP, GENERAL COUNSEL

2019-11-22 M 8,580 $13.90 a 36,993 25,171.00 direct yes

CIAMBRONE WILLIAM - Officer EVP

2019-11-18 A 80,000 a 80,000 0.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments